baber/WOPTO huggingface dataset:
Patent AU-661052-B2 (AU)
Title: Process for the preparation of substituted indoles
Inventor: GERSPACHER MARC DR
IPC: A61P11/00
Filed: 1992-10-21
Granted: 1995-07-13
Abstract: The invention relates to a novel process for the preparation of compounds of the formula I <IMAGE> in which R is straight-chain C2-C4-alk-1-en-1-yl, and salts of these compounds, as well as a novel starting material and the use thereof.
Patent AU-664210-B2 (AU)
Title: Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies
Inventor: KILBOURN ROBERT G
IPC: A61K31/715
Filed: 1992-09-26
Granted: 1995-11-09
Abstract: An anti-hypotensive formulation comprising an essentially arginine-free or low arginine (less than about 0.1 %, most preferably, about 0.01 %) containing mixture of amino acids is provided. The formulations may further include ornithine, citrulline or both. Combination regimens of the described TPN solutions and an arginine analog, or the TPN formations with an anti-endotoxine antibody, an interleukin-1 receptor antagonist, or an anti-tumor necrosis antibody are also provided. Methods for prophylaxis and treatment of systemic hypotension in employing these combination regimens are also provided. A method for treating hypotension caused by nitric oxide synthesis, through administering a low or essentially arginine-free parenteral formulation is described. Methods for treating an animal in septic shock are also disclosed. Prophylaxis or treatment of systemic hypotension, particularly that hypotension incident to chemotherapeutic treatment with biologic response modifiers, such as tumor necrosis factor or interleukin-1 or -2, may be accomplished through the administration of the defined anti-hypotensive formulations or combination regimens with a TPN formulation until physiologically acceptable systolic blood pressure levels are achieved in the animal. Treatment of an animal for septic shock induced by endotoxin may also be accomplished by administering to the animal the arginine-free formulations described. Methods for providing nutritional support for an animal at risk of or in septic shock may also be provided through the administration of an arginine-free formulation or the combination regimens.
Patent AU-661517-B2 (AU)
Title: Vapour absorbent compositions
Inventor: ATKINSON STEPHEN
IPC: C09K5/04
Filed: 1992-11-05
Granted: 1995-07-27
Abstract: PCT No. PCT/GB92/02050 Sec. 371 Date May 6, 1994 Sec. 102(e) Date May 6, 1994 PCT Filed Nov. 5, 1992 PCT Pub. No. WO93/09198 PCT Pub. Date May 13, 1993An absorbent for use in absorption refrigeration systems, air conditioning systems, heat pumps or dehumidifiers comprising a solution of potassium formate. The absorbent is relatively non-toxic and relatively non-corrosive towards metals. The absorbent is generally water-based but may also comprise ammonia or methanol. Additives such as corrosion inhibitors or other absorbent salts may be included.
Patent AU-714552-B2 (AU)
Title: High solubility size composition for fibers
Inventor: PIRET WILLY HENRI
IPC: C03C25/10
Filed: 1997-05-06
Granted: 2000-01-06
Abstract: A high solubility size composition is provided which may be applied to glass fibers useful for reinforcing polymeric materials. The size composition includes: a first film former comprising a polyester-based thermoplastic polyurethane derived from a saturated, non-crosslinkable polyester; a second film former comprising at least one ingredient selected from i) a vinyl acetate glycidyl methacrylate copolymer and ii) a mixture of a vinyl acetate glycidyl methacrylate copolymer and a vinyl acetate homopolymer; a silane coupling agent; and water. Using glass fibers coated with the high solubility size composition allows the advantageous production of low-pigmented or non-pigmented molded parts having enhanced surface appearance and color uniformity.
Patent AU-684198-B2 (AU)
Title: Method and apparatus for crop spraying
Inventor: BENEST ROGER SIDNEY
IPC: A01M7/00
Filed: 1995-08-31
Granted: 1997-12-04
Abstract: A dropleg row crop sprayer (12) senses boom height and tilt from ground-contacting droplegs (46) signalling through potentiometers (74, 76) to a boom control mechanism (84). The droplegs follow crop row wandering through a driven carriage (44). Dropleg attitude is assisted by a cam control system (94, 96). The boom (20, 21) floats through a spring suspension system (128, 138) and is damped by frictional abutment of the boom portions (20, 21), thereby permitting a single actuator (106) to control attitude. A lost motion linkage (126) protects the actuator (106) from snatch loads. Spray control is effected by use of microdroplets discharged from the droplegs (46) below the row crop leaf canopy which protects the droplets from wind turbulence, while electrostatic charges and droplet-energising air flow act to assit crop coating. Where conventional spray droplets are used, the spray direction is fore/aft of the row to minimize ground speed effects. <IMAGE>
Patent AU-566173-B2 (AU)
Title: Dispensing measures of liquids
Inventor: STEINER WALTER
IPC: G01F11/26
Filed: 1984-07-11
Granted: 1987-10-08
Abstract: A device for the dosed dispensing of liquid from a storage container through a delivery tube which comes out of a lower pouring chamber. The dispensing takes place upon the second upside down turning of the container. A cup-shaped housing is divided by a transverse wall into an upper chamber and the lower pouring chamber, the pouring chamber and the upper chamber communicating with each other through a flow hole. The transverse wall is traversed by a feed tube which opens above it. Projecting above this is the delivery tube. An air passage extends through the transverse wall. At least three feed tubes are arranged in symmetrical angular distribution with a respective air passage opening arranged between them.
Patent AU-723144-B2 (AU)
Title: A method for diagnosis and prognosis of cancer
Inventor: ZETTER BRUCE R
IPC: C12Q1/68
Filed: 1997-06-13
Granted: 2000-08-17
Abstract: The present inventors have discovered that humans have a gene that encodes a novel protein of the thymosin  beta  family. This novel protein, herein referred to as thymosin  beta 15, has the ability to bind and sequester G-actin, like other members of the thymosin  beta  family, but unlike what is known about other members also directly regulates cell motility in prostatic carcinoma cells. A cDNA of the human thymosin  beta 15 gene (SEQ ID NO: 1) and having deduced the amino acid sequence (SEQ ID NO: 2) was isolated. The present inventors have shown that the enhanced transcripts (mRNA) and expression of the thymosin  beta 15 gene in non-testicular cells has a high correlation to disease state in a number of cancers, such as prostate, lung, melanoma and breast cancer, particularly metastatic cancers. Accordingly, discovering enhanced levels of transcript or gene product in non-testicular tissues can be used in not only a diagnostic manner, but a prognostic manner for particular cancers. <IMAGE>
Patent AU-620623-B2 (AU)
Title: A container comprising a supporting frame of a relatively rigid, dimensionally stable material and a flexible sleeve member
Inventor: BOOTS GERARDUS ANTHONIUS MARIA
IPC: B65D61/00
Filed: 1989-06-14
Granted: 1992-02-20
Abstract: A container is provided, which comprises a supporting frame including rod-like elements of a relatively rigid, dimensionally stable material, and a flexible sleeve member (14) forming a receptacle for substances, materials, goods and the like to be packaged. The supporting frame includes at least three circumferential walls, a top wall and a bottom wall. A rod-like element is provided at the transition of a circumferential wall to an adjacent circumferential wall. The sleeve member is provided with at least three flexible loop members (15) each extending around a rod-like element and being attached to the sleeve member at two places spaced apart in the circumferential direction of the sleeve member. Each loop member has a length, measured from one place of attachment to the sleeve member to the other, which is a multiple of the circumference of the enveloped rod-like element. The distance between the places of attachment, measured along the sleeve member, is a multiple of the largest transverse dimension of the enveloped rod-like element. The arrangement is such that the loop members keep the sleeve member at all times within the circumference of the frame, at any rate when the sleeve member contains substances, materials, goods or the like.
Patent AU-703105-B2 (AU)
Title: Novel prostaglandin synthase inhibitors
Inventor: BATT DOUGLAS GUY
IPC: C07D263/32
Filed: 1995-09-26
Granted: 1999-03-18
Abstract: This invention relates to ortho substituted phenyl compounds as inhibitors of prostaglandin synthase, to pharmaceutical compositions comprising such compounds and to methods of using such compounds as antiinflammatory and antipyretic agents. The class of compounds useful in this method of treatment is represented by Formula I below:    <IMAGE>  (I)
Patent AU-775969-B2 (AU)
Title: Synthesis of ruthenium or osmium metathesis catalysts
Inventor: GRUBBS ROBERT H
IPC: B01J31/00
Filed: 2001-05-04
Granted: 2004-08-19
Abstract: The present invention relates to the synthesis of ruthenium and osmium carbene metathesis catalysts of the formula   
or of the formula   
by reacting unsaturated alkene or alkyne compounds with hydrogen containing ruthenium or osmium complexes as   
and to the synthesis of certain of the hydrogen containing ruthenium or osmium complexes used in the synthetic methods mentioned above.
Patent AU-744138-B2 (AU)
Title: Watertight battery compartment cover with latch actuated o-ring seal
Inventor: HERMANN ROBERT A
IPC: H01M50/213
Filed: 1999-06-04
Granted: 2002-02-14
Abstract: A cover for a battery compartment in a medical device such as an ambulatory pump that is used for infusing a medicinal fluid. The battery compartment cover includes a lever that is pivotal between an open and a closed position. The lever is connected to a plunger that applies a compressive force against an O-ring, which is trapped between a shoulder on a washer through which the plunger extends and an end of the plunger. When the lever is pivoted to its open position, the compressive force on the O-ring is released, enabling the battery compartment cover to be removed from the opening into the battery compartment. However, when the lever is pivoted to its closed position, it draws the plunger outwardly, applying a compressive force to the O-ring that causes the O-ring to expand radially outward, sealing the opening into the battery compartment against the intrusion of water or other liquids and securing the battery compartment cover in engagement with the opening.
Patent AU-616821-B2 (AU)
Title: Method and device for the production of wood sheets from cut wood
Inventor: BINDER HANS
IPC: B27M1/08
Filed: 1989-11-29
Granted: 1991-11-07
Abstract: A method for the production of finished wood sheets from rough cut wood includes the steps of conditioning the rough cut wood, as necessary, to obtain a predetermined moisture content equivalent to a humidity of 50%. The conditioned rough cut wood is cut into predetermined dimensions using a sawdust-free process and then immediately dried to obtain a low moisture content. The dried wood is further treated using a grinding process to eliminate rough edges of the finished sheet.
Patent AU-625976-B2 (AU)
Title: Free-flowing pearl sheen concentrate
Inventor: KAWA ROLF
IPC: C09K23/28
Filed: 1989-12-14
Granted: 1992-07-23
Abstract: A pearl sheen concentrate with a content of pearl sheen-forming components between 15 and 40 wt.% can be produced in the form of a free-flowing aqueous dispersion, if the dispersion also contains 5 to 55 wt.% of non-ionogenic, ampholytic and/or zwitterionic emulsifiers and 0.1 to 5 wt.% of low molecular weight polyhydric alcohols.
Patent AU-700762-B2 (AU)
Title: Artificial skin containing as support biocompatible materials based on hyaluronic acid derivatives
Inventor: SORANZO CARLO
IPC: A61K35/12
Filed: 1996-04-25
Granted: 1999-01-14
Abstract: PCT No. PCT/EP96/01734 Sec. 371 Date Oct. 22, 1997 Sec. 102(e) Date Oct. 22, 1997 PCT Filed Apr. 25, 1996 PCT Pub. No. WO96/33750 PCT Pub. Date Oct. 31, 1996Artificial human skin is disclosed which is based on: (a) a microperforated membrane based on a hyaluronic acid derivative on which keratinocytes have been seeded and cultured; (b) an underlying non-woven tissue based on a hyaluronic acid derivative wherein fibroblasts have been seeded and left to proliferate. The artificial human skin may be used in medical, surgical, diagnostic and controlled release drug delivery applications. The artificial human skin may be safely frozen to -80 DEG  C. or stored in liquid nitrogen in order to have a skin tissue bank.
Patent AU-676250-B2 (AU)
Title: Telephone network voice recognition and verification using selectively-adjustable signal thresholds
Inventor: HUNT ALAN K
IPC: H04M3/38
Filed: 1993-11-24
Granted: 1997-03-06
Abstract: A method for enabling a caller to obtain access to one or more services via a telephone network by speaking a password is described. The method begins by establishing at least one predetermined threshold value for a speaker verification signal. For each spoken character of the password, the method generates a set of parameters using a voice verification feature transformation. After entry and recognition of the password, the sets of parameters are used to generate a speaker verification signal for the password. Upon the occurrence of a predetermined call condition, the predetermined threshold value is adjusted to increase the level of security in the verification algorithm. If the signal verification signal for the password has a predetermined relationship with respect to the adjusted threshold value, the caller's identity is accepted. If not, the caller may be asked to answer certain personal questions before his or her identity is accepted.
Patent AU-647397-B2 (AU)
Title: Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
Inventor: BREWER MICHAEL T
IPC: C12R1/91
Filed: 1990-07-16
Granted: 1994-03-24
Abstract: At least two substantially purified tumor necrosis factor (TNF) inhibitors are disclosed which are glycoproteins that are active against TNF. The isolation of 30kDa and 40KDa TNF inhibitors from urine is disclosed. The deglycosylated form of the 30kDa TNF inhibitor and 40kDa TNF inhibitor are described as being active against TNF. The 40kDa TNF inhibitor is active against both TNF alpha and TNF beta. The amino acid sequence of the 30kDa TNF inhibitor and the 40kDa TNF inhibitor are disclosed. Methods for isolating the TNF inhibitors from human U937 cell medium are also described. <IMAGE>
Patent AU-539558-B2 (AU)
Title: Processing of mushrooms with reduced weight-loss by impregnation
Inventor: FERGUSON ANDREW M
IPC: A23L3/00
Filed: 1980-06-05
Granted: 1984-10-04
Abstract: Freshly picked washed mushrooms are subjected to a modified atmosphere and infused by application of positive or negative pressure with a solution containing a particulate heat stable gel forming material. Upon blanching in boiling water the weight loss experienced is reduced from a normal 25% to 33% loss to between a 2% loss and a 5% or more weight gain.
Patent AU-725365-B2 (AU)
Title: Joint endoprosthesis
Inventor: KELLER ARNOLD
IPC: A61F2/30
Filed: 1998-03-23
Granted: 2000-10-12
Abstract: Joint endoprosthesis with an attachment part which can be attached and removed along a guide provided on the endoprosthesis, and with a screw (5) for locking the attachment part. This screw is arranged in the area of overlapping surface portions (7, 8) of the prosthesis and of the attachment part. A first surface portion (7) includes a threaded bore (13) receiving the screw (5). The screw shank has, adjacent to the screw head (10), a threaded section (12), adjacent to this a section (14) of reduced thickness, and adjacent to this a thickened end (15). The section (14) of reduced thickness lies in the area of the second surface portion (8), and namely in a slit (6) which extends in the direction of the guide and whose width is smaller than the thickness of the thickened end (15).
Patent AU-707434-B2 (AU)
Title: Constructional toys
Inventor: MOTT JONATHAN CHRISTOPHER
IPC: A63H33/10
Filed: 1996-06-19
Granted: 1999-07-08
Abstract: PCT No. PCT/GB96/01496 Sec. 371 Date Dec. 29, 1997 Sec. 102(e) Date Dec. 29, 1997 PCT Filed Jun. 19, 1996 PCT Pub. No. WO97/01383 PCT Pub. Date Jan. 16, 1997A constructional toy including a plurality of main building blocks, preferably square and triangular in shape, all having identical grooves in their side faces, the mouth of each groove being narrower than the rest of the groove. The blocks are connected together by connecting elements each having a cross section in the shape of a symmetrical star having 2N points, where N is at least three. Each connecting element is a sliding fit in the grooves in the main blocks, with N adjacent points of its star-shaped cross section trapped in the groove and the other N points outside the groove, thus enabling the blocks to be connected together side face to side face.
Patent AU-738777-B2 (AU)
Title: Aromaheterocyclic derivatives
Inventor: NAKAZATO ATSURO
IPC: C07D401/06
Filed: 1998-03-18
Granted: 2001-09-27
Abstract: <CHEM>      Heteroaromatic derivatives represented by general formula (I) or pharmacologically acceptable salts thereof wherein Z represents a group represented by general formula (II), (III), (IV) or (V) (wherein Ar<1> represents phenyl optionally substituted by a halogen or C1-5 alkyl; R<2> represents a C1-5 alkyl; and Y represents hydrogen, mercapto, a C1-5, alkylthio, or amino optionally substituted by one or two C1-5 alkyls); Ar<2> represents phenyl optionally having one or two substituents selected among halogens, C1-5 alkyls, C1-5 alkoxys, hydroxy, and trifluoromethyl; B<1>-B<2> represents CH-CO or C=C(R<1>) (wherein R<1> represents hydrogen or a C1-5 alkyl); and n is an integer of 1 to 4. The compounds are dopamine D4 receptor antagonists having a psychotropic action without causing extrapyramidal disorders.
Patent AU-533216-B2 (AU)
Title: Underground storage
Inventor: FURMAN VLADIMIR
IPC: B65G5/00
Filed: 1981-02-03
Granted: 1983-11-10
Abstract: A pool for the storage of fluids under pressure. The pool is sealed from above by a membrane (6) that is elastic under the storage pressure and which bears an incoherent protective layer (7). The elastic membrane (6) varies between fully deflated and inflated states in dependence on the amount of fluid in the pool and the protective layer (7) follows such variations.
Patent AU-697977-B2 (AU)
Title: O6-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells
Inventor: MCMURRY THOMAS BRIAN
IPC: C07D473/18
Filed: 1994-06-08
Granted: 1998-10-22
Abstract: O &cir& _<6>-hetarylalkyl- or naphthylalkylguanine derivatives of formula (I) wherein Y is H, ribosyl, deoxyribosyl, or R"XCHR"', wherein X is O or S, R'' and R''' are alkyl, or substituted derivatives thereof; R' is H, or alkyl or hydroxyalkyl; R is (i) a cyclic group having at least one 5- or 6-membered heterocyclic ring, optionally with a carbocyclic or heterocyclic ring fused thereto, the or each heterocyclic ring having at least one hereto atom chosen from O, N or S, or a substituted derivative thereof; or (ii) naphthyl or a substituted derivative thereof; and pharmaceutically acceptable salts thereof, exhibit the ability to deplete O &cir& _<6>-alkylguanine-DNA alkyltransferase (ATase) activity. A process for preparation of the compounds is described. The compounds have utility in combination with alkylating agents in the chemotherapeutic treatment of tumour cells.
Patent AU-753421-B2 (AU)
Title: A scaling independent technique for watermarking images
Inventor: RYAN JOHN O
IPC: H04N7/26
Filed: 2000-08-01
Granted: 2002-10-17
Abstract: A robust technique to prevent illicit copying of video information notwithstanding the use of image scaling. A watermark is embedded into the video signal (e.g., DVD's content or other video sources) at different scales (i.e., sizes). The watermark is maintained at each scale for a predetermined time duration that is sufficient to allow the detector circuit in a DVD-recorder, DVHS recorder, DVCR, or any other digital format recorder to detect, extract, and process information contained in the watermark. At the end of the predetermined time duration, the watermark is changed to a different scale preferably on a pseudo-random basis to ensure that each one of all the scales in a predetermined scaling range is achieved a predetermined number of times. Thereby the recorder shuts off a number of times during play of the content, each time the detector circuit senses the watermark.
Patent AU-728929-B2 (AU)
Title: Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes
Inventor: SRIVASTAVA PRAMOD K
IPC: A61K35/12
Filed: 1996-09-11
Granted: 2001-01-18
Abstract: The present invention relates to methods and compositions for enhancing immunological responses and for the prevention and treatment of infectious diseases or primary and metastatic neoplastic diseases based on the administration of macrophages and/or other antigen presenting cells (APC) sensitized with heat shock proteins non-covalently bound to peptide complexes and/or antigenic components. APC are incubated in the presence of hsp-peptide complexes and/or antigenic components in vitro. The sensitized cells are reinfused into the patient with or without treatment with cytokines including but not limited to interferon- alpha , interferon- alpha , interleukin-2, interleukin-4, interleukin-6 and tumor neurosis factor.
Patent AU-630791-B2 (AU)
Title: Casing hanger seal assembly
Inventor: BURTON JAMES A
IPC: F16L21/02
Filed: 1991-03-15
Granted: 1992-11-05
Abstract: The present invention relates to an improved seal assembly for sealing between the interior sealing surface of a well housing (12) and the exterior sealing surface of a hanger (16) landed within the well housing. The assembly includes a seal body (20) having a pair of outer lips (74, 76) diverging outwardly for sealing against the housing interior sealing surface and an interior series of annular ridges (8, 2) which have a diameter smaller than the outer diameter of the hanger exterior sealing surface, and an upper energizer (24) and a lower energizer (22) for coacting with said lips to move the lips into sealing position and to store the energy of setting to ensure sealing engagement of the lips. In some forms of the invention the energy is stored by viture of the lips being of a relatively low yield strength material as compared to the energizers which have a higher yield strength. Also structure is provided in some of the forms of the invention to store both radial and axial lip loading forces. <IMAGE>
Patent AU-688363-B2 (AU)
Title: Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
Inventor: MASCARENHAS DESMOND
IPC: C12R1/19
Filed: 1994-08-02
Granted: 1998-03-12
Abstract: The invention is directed to the use of a fusion partner that does not contain a leader sequence, as a means to increase the solubility and activity of recombinant polypeptides by facilitating the expression of fusion proteins, which are then transported out of the cytoplasm. The invention includes a nucleic acid encoding a fusion polypeptide comprising a mature interleukin-1-like polypeptide or a leader-deleted-translocating polypeptide, and a polypeptide of interest; as well as host cells comprising such nucleic acids, and fusion proteins so encoded. The invention also encompasses methods of using such nucleic acids to produce recombinant fusion polypeptides, mature polypeptides of interest, and purified compositions thereof.